Literature DB >> 17275903

Hypoxia and lactate production in trophoblast cells.

H H Kay1, S Zhu, S Tsoi.   

Abstract

The etiology of preeclampsia is unknown but is thought to be related to hypoxia in the placenta. We previously reported that the enzyme lactate dehydrogenase (LDH) has increased activity and gene expression in placentas from preeclamptic pregnancies [Tsoi SCM, Zheng J, Xu F, Kay HH. Differential expression of lactate dehydrogenase isozymes (LDH) in human placenta with high expression of LDH-A(4) isozyme in the endothelial cells of pre-eclampsia villi. Placenta 2001;22:317-22]. LDH is responsible for pyruvate conversion to lactate through glycolysis. In this study, we further investigated the role of hypoxia in primary trophoblast cells and a cultured cell line, JEG3 cells, to obtain a better understanding of how it affects the activities of lactate dehydrogenase, lactate production and regulatory genes, as a possible model for preeclampsia. Primary trophoblast cells and JEG3 cells were cultured under 1% oxygen. At 6, 12 and 24h, cells were analyzed for LDHA and LDHB isozyme activities, mRNA and protein expression compared to standard culture conditions. Lactate was measured from cell medium. The hypoxia inducible transcription factor (HIF-1alpha) protein expression was confirmed by western blot. Two lactate transporters (MCT1 and MCT4) mRNA and protein expression were also studied under hypoxia. Finally, lactate was measured in plasma obtained from patients with severe preeclampsia. Under hypoxic conditions, LDHA mRNA is increased in primary trophoblast cells and JEG3 cells. The HIF-1alpha protein expression is higher in hypoxia-treated JEG3 cells than control. LDHA isozyme activity and its protein expression are increased most significantly at 24h of culture under hypoxia. However, LDHB protein is unchanged while its mRNA is decreased. Lactate secretion from JEG3 cells under hypoxia is increased, as is the lactate levels in the plasma from preeclampsia patients. Of the two lactate transporters studied, MCT4 mRNA and protein level are increased under hypoxia. Our findings support the role of hypoxia in inducing HIF-1alpha activity in trophoblasts and increasing LDH transcription as well as its activity. Higher levels of lactate are produced and secreted which may contribute to the higher lactate levels in plasma of preeclamptic patients. These mechanisms may be important in the pathophysiology of preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17275903     DOI: 10.1016/j.placenta.2006.11.011

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  22 in total

1.  Staphylococcus aureus induces hypoxia and cellular damage in porcine dermal explants.

Authors:  Abdul G Lone; Erhan Atci; Ryan Renslow; Haluk Beyenal; Susan Noh; Boel Fransson; Nehal Abu-Lail; Jeong-Jin Park; David R Gang; Douglas R Call
Journal:  Infect Immun       Date:  2015-04-06       Impact factor: 3.441

2.  Ex vivo perfusion of mid-to-late-gestation mouse placenta for maternal-fetal interaction studies during pregnancy.

Authors:  Nick Goeden; Alexandre Bonnin
Journal:  Nat Protoc       Date:  2012-12-13       Impact factor: 13.491

3.  USP22 controls multiple signaling pathways that are essential for vasculature formation in the mouse placenta.

Authors:  Evangelia Koutelou; Li Wang; Andria C Schibler; Hsueh-Ping Chao; Xianghong Kuang; Kevin Lin; Yue Lu; Jianjun Shen; Collene R Jeter; Andrew Salinger; Marenda Wilson; Yi Chun Chen; Boyko S Atanassov; Dean G Tang; Sharon Y R Dent
Journal:  Development       Date:  2019-02-22       Impact factor: 6.868

4.  LDH (Lactate Dehydrogenase): A Biochemical Marker for the Prediction of Adverse Outcomes in Pre-eclampsia and Eclampsia.

Authors:  Anupama Dave; Laxmi Maru; Astha Jain
Journal:  J Obstet Gynaecol India       Date:  2014-12-02

5.  Lactate dehydrogenase production in hepatocytes is increased at an early stage of acute liver failure.

Authors:  Kazuhiro Kotoh; Masaki Kato; Motoyuki Kohjima; Masatake Tanaka; Masayuki Miyazaki; Kazuhiko Nakamura; Munechika Enjoji; Makoto Nakamuta; Ryoichi Takayanagi
Journal:  Exp Ther Med       Date:  2011-01-19       Impact factor: 2.447

Review 6.  Placental metabolic reprogramming: do changes in the mix of energy-generating substrates modulate fetal growth?

Authors:  Nicholas P Illsley; Isabella Caniggia; Stacy Zamudio
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

7.  Antithrombin III injection via the portal vein suppresses liver damage.

Authors:  Masayuki Miyazaki; Masaki Kato; Masatake Tanaka; Kosuke Tanaka; Shinichiro Takao; Motoyuki Kohjima; Tetsuhide Ito; Munechika Enjoji; Makoto Nakamuta; Kazuhiro Kotoh; Ryoichi Takayanagi
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

8.  Investigation into the potential for hypoxic interior of neoplasms to enhance HSPA expression in glioma.

Authors:  Glenda M Beaman; David A Phoenix; Sarah R Dennison; Lee K Chatfield
Journal:  Mol Cell Biochem       Date:  2014-05-16       Impact factor: 3.396

Review 9.  Lactate transporters in the context of prostate cancer metabolism: what do we know?

Authors:  Nelma Pértega-Gomes; Fátima Baltazar
Journal:  Int J Mol Sci       Date:  2014-10-13       Impact factor: 5.923

10.  Deuterium Magnetic Resonance Imaging and the Discrimination of Fetoplacental Metabolism in Normal and L-NAME-Induced Preeclamptic Mice.

Authors:  Stefan Markovic; Tangi Roussel; Michal Neeman; Lucio Frydman
Journal:  Metabolites       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.